Vivendy Therapeutics Company
Vivendy Therapeutics Ltd. engages in the development of an enzyme replacement therapy for Morbus Morquio, a rare lysosomal storage disease based on a gene deficiency.
The company was founded in 2006 and is based in Basel, Switzerland.
The company was founded in 2006 and is based in Basel, Switzerland.
Technology:
Prevention
Industry:
Regenerative medicine
Headquarters:
Basel, Basel-Stadt, Switzerland
Founded Date:
2006
Employees Number:
1-10
Funding Status:
Early Stage Venture
Register and Claim Ownership